Novo Holdings A/S 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-18 1:30 pm Sale | 2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 1,760,000 4.800% | -129,127 (-6.84%) | Filing |
| 2022-08-02 3:31 pm Sale | 2022-08-01 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 1,889,127 5.900% | -310,873 (-14.13%) | Filing |
| 2022-04-08 2:49 pm Sale | 2022-03-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 2,200,000 6.900% | -245,147 (-10.03%) | Filing |
| 2021-08-24 4:32 pm Unchanged | 2021-08-19 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 2,445,147 8.000% | 0 (Unchanged) | Filing |
| 2020-12-18 4:31 pm Unchanged | 2020-12-15 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Novo Holdings A/S | 2,445,147 8.400% | 0 (Unchanged) | Filing |